General MedicationsOPHTHALMICStandard
QLOSI
PILOCARPINE HYDROCHLORIDE
Standard Dose
0.4%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview QLOSI is listed in Drugs@FDA under application 217836 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient PILOCARPINE HYDROCHLORIDE Form and strength SOLUTION/DROPS;OPHTHALMIC - 0.4% Sponsor ORASIS PHARMS Submission history Latest submission status date: 2023-10-17 00:00:00.
Structured Monograph
Clinical summary
Approval overview QLOSI is listed in Drugs@FDA under application 217836 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient PILOCARPINE HYDROCHLORIDE Form and strength SOLUTION/DROPS;OPHTHALMIC - 0.4% Sponsor ORASIS PHARMS Submission history Latest submission status date: 2023-10-17 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.